Compound class:
Synthetic organic
Comment: LY3509754 is an orally bioavailable, small molecule inhibitor of the proinflammatory cytokine IL-17A [1]. It was intended as an alternative to anti-IL-17A monoclonals for the treatment of psoriasis.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Database Links ![]() |
|
CAS Registry No. | 2452464-73-0 (source: PubChem) |
GtoPdb PubChem SID | 491299946 |
PubChem CID | 154642729 |
Search Google for chemical match using the InChIKey | MVWVCLAORBNXSD-UWVAXJGDSA-N |
Search Google for chemicals with the same backbone | MVWVCLAORBNXSD |
UniChem Compound Search for chemical match using the InChIKey | MVWVCLAORBNXSD-UWVAXJGDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MVWVCLAORBNXSD-UWVAXJGDSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
LY3509754 (links to external site)
Cat. No. HY-139206 |